Goldman Sachs Group Inc Exact Sciences Corp Put Options Transaction History

Goldman Sachs Group Inc

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$42.43 - $70.83 $971,647 - $1.62 Million	22,900 New	22,900 $1.56 Million
Q1 2024 May 15, 2024	SELL	$56.27 - $73.77 $1.41 Million - $1.84 Million	-25,000 Reduced 89.29%	3,000 $207,000
Q4 2023 Feb 13, 2024	BUY	$59.06 - $75.72 $708,720 - $908,640	12,000 Added 75.0%	28,000 $2.07 Million
Q3 2023 May 14, 2024	SELL	$65.94 - $99.04 $791,280 - $1.19 Million	-12,000 Reduced 42.86%	16,000 $1.09 Million
Q2 2023 May 14, 2024	SELL	$62.68 - $95.05 $752,160 - $1.14 Million	-12,000 Reduced 42.86%	16,000 $1.5 Million
Q2 2023 Aug 14, 2023	BUY	$62.68 - $95.05 $1 Million - $1.52 Million	16,000 New	16,000 $1.5 Million

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $9.93B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.